Ipilimumab is a medicine used to treat a type of skin cancer known as metastatic melanoma. It works by stimulating the body's own immune system to fight the cancer cells. It is given as an intravenous (IV) infusion, usually every three weeks for up to four doses. It is usually used in combination with chemotherapy and other treatments. Common side effects of ipilimumab include nausea, vomiting, diarrhea, and fever. More serious side effects, such as inflammation of the lungs, heart, or liver, may also occur.
Ipilimumab is a prescription medication used to treat certain types of cancer. Here's a breakdown of its key features:
- Type of drug: Monoclonal antibody [1].
- Function: Immunotherapy medication that targets a specific protein to activate the immune system against cancer cells [1, 2].
- Conditions treated: Ipilimumab is primarily used for treating advanced melanoma (a type of skin cancer) but may also be used for other cancers in some cases [1, 3].
Here's a deeper look at how Ipilimumab works:
- Mechanism of action: Ipilimumab binds to a protein called CTLA-4 on T cells (immune system cells) [1, 2]. Normally, CTLA-4 helps regulate the immune system's response. Ipilimumab blocks CTLA-4, essentially taking the "brake" off the immune system, allowing T cells to become more active and attack cancer cells [1, 2].
Important considerations:
- Ipilimumab is administered by intravenous (IV) infusion [1].
- It's a prescription medication and should only be used under the supervision of a qualified healthcare professional [1].
- Ipilimumab can cause serious side effects, so it's important to discuss the potential risks and benefits with your doctor before receiving this medication [1].
Here are some additional details about Ipilimumab:
- Brand name: Yervoy is a common brand name for Ipilimumab [1].
- Clinical trials: Ipilimumab has been studied in clinical trials and shown to be effective in treating some types of cancer [1, 3].